Merck & Co Inc (MRK)
131.20
+0.48
(+0.37%)
USD |
NYSE |
Apr 26, 16:00
131.15
-0.05
(-0.04%)
After-Hours: 20:00
Merck Gross Profit (TTM): 45.66B for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 45.66B |
December 31, 2023 | 43.99B |
September 30, 2023 | 43.22B |
June 30, 2023 | 42.55B |
March 31, 2023 | 41.91B |
December 31, 2022 | 41.87B |
September 30, 2022 | 41.57B |
June 30, 2022 | 40.25B |
March 31, 2022 | 38.17B |
December 31, 2021 | 35.08B |
September 30, 2021 | 31.35B |
June 30, 2021 | 29.56B |
March 31, 2021 | 27.87B |
December 31, 2020 | 29.19B |
September 30, 2020 | 25.84B |
June 30, 2020 | 26.33B |
March 31, 2020 | 28.09B |
December 31, 2019 | 27.11B |
September 30, 2019 | 32.24B |
June 30, 2019 | 31.01B |
March 31, 2019 | 29.70B |
December 31, 2018 | 28.78B |
September 30, 2018 | 28.07B |
June 30, 2018 | 27.91B |
March 31, 2018 | 27.68B |
Date | Value |
---|---|
December 31, 2017 | 27.21B |
September 30, 2017 | 26.86B |
June 30, 2017 | 26.97B |
March 31, 2017 | 26.42B |
December 31, 2016 | 25.78B |
September 30, 2016 | 25.50B |
June 30, 2016 | 24.68B |
March 31, 2016 | 24.45B |
December 31, 2015 | 24.56B |
September 30, 2015 | 24.93B |
June 30, 2015 | 24.95B |
March 31, 2015 | 24.96B |
December 31, 2014 | 25.47B |
September 30, 2014 | 25.45B |
June 30, 2014 | 26.04B |
March 31, 2014 | 26.73B |
December 31, 2013 | 27.08B |
September 30, 2013 | 27.94B |
June 30, 2013 | 28.37B |
March 31, 2013 | 29.84B |
December 31, 2012 | 30.82B |
September 30, 2012 | 31.36B |
June 30, 2012 | 31.68B |
March 31, 2012 | 31.35B |
December 31, 2011 | 31.18B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
25.84B
Minimum
Sep 2020
45.66B
Maximum
Mar 2024
35.14B
Average
33.66B
Median
Gross Profit (TTM) Benchmarks
Amgen Inc | 19.74B |
Johnson & Johnson | 61.53B |
Eli Lilly and Co | 27.04B |
Pfizer Inc | 33.54B |
Moderna Inc | 2.061B |